Elicio Therapeutics Closes $15 Million Registered Direct Offering

Mintz has advised Elicio Therapeutics. Alston & Bird has advised the placement agents. Elicio Therapeutics (Nasdaq: ELTX) (“Elicio”), a clinical-stage biotechnology company, has announced the closing…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here